- €41.04bn
- €86.43bn
- -€5.65bn
- 19
- 47
- 83
- 46
2019 December 31st | 2020 December 31st | R2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 7,223 | 7,111 | 11,321 | 3,983 | -5,649 |
Cost of Revenue | |||||
Gross Profit | 6,447 | 6,277 | 10,312 | 2,210 | -7,279 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 3,700 | 1,674 | 5,701 | 4,346 | 3,103 |
Operating Profit | 3,524 | 5,437 | 5,619 | -364 | -8,753 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 3,139 | 5,014 | 5,092 | -605 | -9,185 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1,294 | 3,340 | 2,441 | -575 | -6,608 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 1,187 | 3,269 | 2,290 | -644 | -6,285 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1,147 | 3,229 | 2,252 | -644 | -6,285 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 3.63 | 5.61 | 6.54 | 0.234 | -7.34 |
Dividends per Share |